Differential involvement of nigral subregions in idiopathic parkinson's disease

In this study, the prevalence of abnormality in putative nigrosome 1 and nigrosome 4 (N1 and N4, respectively) was investigated in early versus late‐stage idiopathic Parkinson's disease (IPD) patients. A total of 128 IPD patients (early stage[n = 89]; late stage[n = 39]) and 15 healthy subjects were scanned for high‐resolution (0.5 × 0.5 × 1.0 mm3) multiecho gradient‐recalled echo MRI and dopamine transporter PET imaging. The MRI data were processed for susceptibility map‐weighted imaging (SMWI) to improve a contrast‐to‐noise ratio, and the images were resliced at 0.5 mm to define N1 and N4. When each side of N1 and N4 was assessed separately for the loss of hyperintensity by two independent reviewers, the consensus review results showed that in early‐stage IPD (178 substantia nigras [SNs]), the loss of hyperintensity was observed more often in only the N1 region (65.2%) when compared to in both N1 and N4 regions (34.8%). In late‐stage IPD (78 SNs), on the other hand, the loss in only the N1 region (25.6%) was less prevalent than in both N1 and N4 (74.4%) (P < 0.0001). Additionally, intact SNs (both in N1 and N4) were observed 17 SNs (9.6%) of the early‐stage IPD patients, whereas it was not found in any SNs of the late‐stage IPD patients (P = 0.005). Moreover, involvement of both N1 and N4 on both sides was found in 19.1% of the early‐stage IPD patients, whereas its incidence was higher (61.5%) in the late‐stage IPD patients (P < 0.0001), suggesting that the loss of hyperintensity in IPD progresses from N1 to N4 as the disease advances. Hum Brain Mapp 39:542–553, 2018. © 2017 Wiley Periodicals, Inc.

[1]  F. Yang,et al.  Universality analysis of the existence of substantia nigra "swallow tail" appearance of non-Parkinson patients in 3T SWI. , 2016, European review for medical and pharmacological sciences.

[2]  J S Thornton,et al.  9.4T MR microscopy of the substantia nigra with pathological validation in controls and disease. , 2017, NeuroImage. Clinical.

[3]  Ji Young Yun,et al.  Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECT , 2016, Movement disorders : official journal of the Movement Disorder Society.

[4]  M. Tosetti,et al.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. , 2014, Radiology.

[5]  C Strand,et al.  9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease , 2016, NeuroImage: Clinical.

[6]  H J Gundersen,et al.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[7]  D. Mash,et al.  Dopaminergic innervation of the human striatum in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[8]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[9]  W. Poewe,et al.  Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease , 2017, Movement disorders : official journal of the Movement Disorder Society.

[10]  O. Hornykiewicz,et al.  The discovery of dopamine deficiency in the parkinsonian brain. , 2006, Journal of neural transmission. Supplementum.

[11]  J. J. Lee,et al.  Correlation of 3D FLAIR and Dopamine Transporter Imaging in Patients With Parkinsonism. , 2016, AJR. American journal of roentgenology.

[12]  E. Kim,et al.  Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging. , 2016, Radiology.

[13]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[14]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[15]  R. Bowtell,et al.  Visualization of nigrosome 1 and its loss in PD , 2013, Neurology.

[16]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[17]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[18]  M. Tosetti,et al.  Comparison of 3T and 7T Susceptibility-Weighted Angiography of the Substantia Nigra in Diagnosing Parkinson Disease , 2015, American Journal of Neuroradiology.

[19]  Klaus Seppi,et al.  Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7T MRI , 2014, Neurology.

[20]  J. Lee,et al.  Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality , 2015, American Journal of Neuroradiology.

[21]  M. Tosetti,et al.  Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI , 2016, Journal of Neural Transmission.

[22]  N. Wang,et al.  Using ‘swallow-tail’ sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson’s disease: A susceptibility-weighted imaging study , 2017, European Radiology.

[23]  Dong-Hyun Kim,et al.  Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map‐weighted imaging (SMWI) , 2017, Journal of magnetic resonance imaging : JMRI.

[24]  A. van Cappellen van Walsum,et al.  Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study , 2016, Polish journal of radiology.

[25]  S. Gacinovic,et al.  Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.

[26]  Dorothee P. Auer,et al.  The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T , 2014, PloS one.

[27]  T. Simuni,et al.  Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes? , 2017, Clinical imaging.

[28]  S. Kang,et al.  Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. , 2016, Parkinsonism & related disorders.

[29]  Z. Cho,et al.  Seven‐tesla magnetic resonance images of the substantia nigra in Parkinson disease , 2012, Annals of neurology.

[30]  Martin Styner,et al.  Imaging nigral pathology and clinical progression in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[31]  Michael Schocke,et al.  Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative Parkinsonism , 2015, Movement disorders : official journal of the Movement Disorder Society.

[32]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.